Dexamethasone Conjugation to Biodegradable Avidin-Nucleic-Acid-Nano-Assemblies Promotes Selective Liver Targeting and Improves Therapeutic Efficacy in an Autoimmune Hepatitis Murine Model.
暂无分享,去创建一个
Stefano Fumagalli | Urs Christen | Pietro Invernizzi | Mario Salmona | Paolo Bigini | Margherita Morpurgo | D. Barisani | M. Salmona | S. Fumagalli | M. Morpurgo | R. Bagnati | S. Biffi | U. Christen | Marie Messmer | E. Hintermann | P. Invernizzi | P. Bigini | A. Passoni | Donatella Barisani | Stefania Biffi | L. Talamini | M. Violatto | Renzo Bagnati | Edith Hintermann | M. D. De Simoni | Laura Talamini | Elisabetta Casarin | Martina Bruna Violatto | Luca Russo | Simone Baldan | Camilla Tondello | Marie Messmer | Alessandro Rossi | Alice Passoni | Chiara Toffanin | Sara Gimondi | Maria-Grazia De Simoni | Elisabetta Casarin | A. Rossi | Chiara Toffanin | Luca Russo | S. Gimondi | Simone Baldan | Camilla Tondello | Camilla Tondello
[1] P. Olinga,et al. Targeting dexamethasone to Kupffer cells: Effects on liver inflammation and fibrosis in rats , 2001, Hepatology.
[2] N. Realdon,et al. Optimized avidin nucleic acid nanoassemblies by a tailored PEGylation strategy and their application as molecular amplifiers in detection. , 2010, Bioconjugate chemistry.
[3] T. Park,et al. Diverse Applications of Nanomedicine , 2017, ACS nano.
[4] M. Manns,et al. Breaking tolerance to the natural human liver autoantigen cytochrome P450 2D6 by virus infection , 2008, The Journal of experimental medicine.
[5] Bangmao Wang,et al. Altered function of monocytes/macrophages in patients with autoimmune hepatitis , 2016, Molecular medicine reports.
[6] T. Luedde,et al. Fluorescent cell-traceable dexamethasone-loaded liposomes for the treatment of inflammatory liver diseases. , 2015, Biomaterials.
[7] M. Morbidelli,et al. Biocompatible Polymer Nanoformulation To Improve the Release and Safety of a Drug Mimic Molecule Detectable via ICP-MS. , 2017, Molecular pharmaceutics.
[8] K. Fu,et al. Synthesis and Evaluation of a Well-defined HPMA Copolymer–Dexamethasone Conjugate for Effective Treatment of Rheumatoid Arthritis , 2008, Pharmaceutical Research.
[9] K. Dawson,et al. Elution of Labile Fluorescent Dye from Nanoparticles during Biological Use , 2011, PLoS ONE.
[10] A. Buda,et al. Discrimination between ulcerative colitis and Crohn's disease using phage display identified peptides and virus-mimicking synthetic nanoparticles. , 2017, Nanomedicine : nanotechnology, biology, and medicine.
[11] M. Ammirati,et al. Efficient Liver Targeting by Polyvalent Display of a Compact Ligand for the Asialoglycoprotein Receptor. , 2017, Journal of the American Chemical Society.
[12] J. Neuberger,et al. Transplantation in autoimmune liver diseases. , 2008, World journal of gastroenterology.
[13] Pietro Invernizzi,et al. Geoepidemiology of autoimmune liver diseases. , 2010, Journal of autoimmunity.
[14] W J Jusko,et al. Prednisolone Pharmacokinetics and Pharmacodynamics in Relation to Sex and Race , 2001, Journal of clinical pharmacology.
[15] U. Christen,et al. The CYP2D6 Animal Model: How to Induce Autoimmune Hepatitis in Mice , 2012, Journal of visualized experiments : JoVE.
[16] M. Fernández-Rojo,et al. Caveolin-1 Function in Liver Physiology and Disease. , 2016, Trends in molecular medicine.
[17] M. Wilchek,et al. Natural antibodies to avidin in human serum. , 1993, Immunology letters.
[18] J. Pfeilschifter,et al. Mechanism of autoimmune hepatic fibrogenesis induced by an adenovirus encoding the human liver autoantigen cytochrome P450 2D6. , 2013, Journal of autoimmunity.
[19] N. Realdon,et al. In vivo fate of avidin-nucleic acid nanoassemblies as multifunctional diagnostic tools. , 2014, ACS nano.
[20] J. Pfeilschifter,et al. Non-alcoholic fatty liver disease (NAFLD) potentiates autoimmune hepatitis in the CYP2D6 mouse model. , 2016, Journal of autoimmunity.
[21] Ian D. McGilvray,et al. Mechanism of hard nanomaterial clearance by the liver , 2016, Nature materials.
[22] Giovanni Paganelli,et al. Therapeutic use of avidin is not hampered by antiavidin antibodies in humans. , 2010, Cancer biotherapy & radiopharmaceuticals.
[23] P. Invernizzi. Liver auto-immunology: the paradox of autoimmunity in a tolerogenic organ. , 2013, Journal of autoimmunity.
[24] A. Czaja,et al. Decreased fibrosis during corticosteroid therapy of autoimmune hepatitis. , 2004, Journal of hepatology.
[25] Aurelian Radu,et al. DNA condensation by high‐affinity interaction with avidin , 2004, Journal of molecular recognition : JMR.
[26] N. Realdon,et al. Improvement and extension of anti-EGFR targeting in breast cancer therapy by integration with the Avidin-Nucleic-Acid-Nano-Assemblies , 2018, Nature Communications.
[27] N. Realdon,et al. Characterization of multifunctional nanosystems based on the avidin-nucleic acid interaction as signal enhancers in immuno-detection. , 2012, Analytical chemistry.
[28] N. Realdon,et al. A New ELISA Using the ANANAS Technology Showing High Sensitivity to diagnose the Bovine Rhinotracheitis from Individual Sera to Pooled Milk , 2016, PloS one.
[29] K. Landfester,et al. Imaging of Polymeric Nanoparticles: Hard Challenge for Soft Objects , 2016 .
[30] J. Bostwick,et al. Psychiatric adverse effects of corticosteroids. , 2006, Mayo Clinic proceedings.
[31] Akshay Jain,et al. The principles and applications of avidin‐based nanoparticles in drug delivery and diagnosis , 2017, Journal of controlled release : official journal of the Controlled Release Society.
[32] M. Wauben,et al. Complete remission of experimental arthritis by joint targeting of glucocorticoids with long-circulating liposomes. , 2003, Arthritis and rheumatism.
[33] G. Sims,et al. A method for the estimation of polyethylene glycol in plasma protein fractions. , 1980, Analytical biochemistry.
[34] S. Duarte,et al. Matrix metalloproteinases in liver injury, repair and fibrosis , 2015, Matrix biology : journal of the International Society for Matrix Biology.
[35] Yechezkel Barenholz,et al. Amphipathic weak acid glucocorticoid prodrugs remote-loaded into sterically stabilized nanoliposomes evaluated in arthritic rats and in a Beagle dog: a novel approach to treating autoimmune arthritis. , 2008, Arthritis and rheumatism.
[36] G. Mieli-Vergani,et al. Autoimmune hepatitis. , 2011, Journal of hepatology.
[37] J. Pfeilschifter,et al. Molecular mimicry rather than identity breaks T-cell tolerance in the CYP2D6 mouse model for human autoimmune hepatitis. , 2013, Journal of autoimmunity.